Teradyne price target lowered to $100 from $130 at Citi

Citi analyst Atif Malik lowered the firm’s price target on Teradyne (TER) to $100 from $130 and keeps a Buy rating on the shares. The stock dropped 17% yesterday after the company updated its near-term outlook during the investor day, the analyst tells investors in a research note. The firm says that due to uncertainties around tariffs and restrictions, Teradyne sees broad-based push outs. Teradyne should guide one quarter a time given its limited visibility and in-line with other equipment peers, contends Citi.